1. Home
  2. SSM vs PMCB Comparison

SSM vs PMCB Comparison

Compare SSM & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sono Group N.V. Ordinary Shares

SSM

Sono Group N.V. Ordinary Shares

HOLD

Current Price

$2.12

Market Cap

6.4M

Sector

N/A

ML Signal

HOLD

Logo PharmaCyte  Biotech Inc.

PMCB

PharmaCyte Biotech Inc.

HOLD

Current Price

$0.45

Market Cap

6.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SSM
PMCB
Founded
2016
1996
Country
Germany
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4M
6.3M
IPO Year
2021
2001

Fundamental Metrics

Financial Performance
Metric
SSM
PMCB
Price
$2.12
$0.45
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.2M
87.9K
Earning Date
05-20-2026
03-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1,462,987.20
N/A
Revenue Next Year
$48.49
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.20
$0.47
52 Week High
$10.54
$1.51

Technical Indicators

Market Signals
Indicator
SSM
PMCB
Relative Strength Index (RSI) 37.01 24.65
Support Level N/A N/A
Resistance Level $4.50 $0.57
Average True Range (ATR) 0.59 0.03
MACD -0.06 -0.00
Stochastic Oscillator 4.76 9.16

Price Performance

Historical Comparison
SSM
PMCB

About SSM Sono Group N.V. Ordinary Shares

Sono Group NV is engaged in the field of solar-powered electric mobility. With its proprietary solar technology, the company is able to integrate solar panels into a vehicle's bodywork, using energy captured from the sun to charge the vehicle's battery. The group is engaged in the design and development of its own first solar electric vehicle, the Sion. Its Products and services include Complete Solar Solutions, Solar Charge Controllers, Solar Modules, Data Services, and Engineering Services. The company's single business segment manages the financing, research and development, and product commercialization.

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a biotechnology company focused on developing cellular therapies for cancer based on its proprietary cellulose-based live cell encapsulation technology, Cell-in-a-Box. The technology is intended to be used as a platform for therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC). The current generation of the Company's product candidate is CypCaps. The Company is preparing to commercialize cellular therapies for cancer and advance clinical research and development, including a clinical trial in LAPC using encapsulated live cells. Its candidate therapy involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active, cancer-killing form.

Share on Social Networks: